<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSES: Until now, limited data are available about the potential effect of coexisting small vessel disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>) on the long-term outcome of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with intracranial large artery <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (ILAA) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A prospective study was performed on 293 patients with symptomatic ILAA, who were divided into 4 groups (group I, single intracranial large artery <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (SILAA) without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>; group II, multiple intracranial large arteries <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (MILAA) without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>; group III, SILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>; group IV, MILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>) and followed up for recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The 3-year cumulative risks of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> were 18% for SILAA without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>, 38% for MILAA without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>, 21% for SILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> and 34% for MILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The 3-year cumulative risks of <z:hpo ids='HP_0011420'>death</z:hpo> were 6, 7, 20 and 22%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Compared with SILAA without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e>, more recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> occurred in MILAA without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> (log-rank 3.83; p = 0.050) and MILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> (log-rank 7.79; p = 0.014), and the higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> (log-rank 9.472; p = 0.002) was found in group MILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A Cox proportional-hazards regression model showed that MILAA with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> may be a predictor of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> (hazard ratio 2.001; 95% CI 1.108-3.934; p = 0.044), and a borderline predictor for <z:hpo ids='HP_0011420'>death</z:hpo> (hazard ratio 3.180; 95% CI 0.895-10.987; p = 0.073) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Coexisting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVD</z:e> is very common and may predict poor outcome in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients with symptomatic ILAA </plain></SENT>
</text></document>